SUNPHARMA2023-01-012023-03-31 SUNPHARMA2023-01-012023-03-31 SUNPHARMA2023-01-012023-03-31in-bse-fin:OneOperatingExpenses01Member SUNPHARMA2023-01-012023-03-31in-bse-fin:OneOperatingExpenses02Member SUNPHARMA2023-01-012023-03-31in-bse-fin:FourOperatingExpenses01Member SUNPHARMA2023-01-012023-03-31in-bse-fin:FourOperatingExpenses02Member SUNPHARMA2023-03-31 SUNPHARMA2023-01-012023-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SUNPHARMA2023-01-012023-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SUNPHARMA2023-01-012023-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member SUNPHARMA2023-01-012023-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524715 SUNPHARMA NOTLISTED Sun Pharmaceutical Industries Limited Equity 2022-04-01 2023-03-31 2023-05-26 2023-05-11 INR Millions Yearly 10:40:00 14:35:00 2023-05-26 2023-05-26 true Cash Flow Indirect Declaration of unmodified opinion Single segment Pharmaceuticals 2023-01-01 2023-03-31 Audited Standalone 59482200000.00 1203000000.00 60685200000.00 11898600000.00 2623600000.00 -1326400000.00 5290500000.00 1614500000.00 4119800000.00 17389400000.00 41610000000.00 19075200000.00 -29377900000.00 -10302700000.00 -94500000.00 0.00 -94500000.00 0.00 -10208200000.00 0.00 0.00 0.00 0.00 -10208200000.00 409400000.00 -9798800000.00 0.00 0.00 2399300000.00 1 -4.30 -4.30 0.00 0.00 -4.30 -4.30 For detailed notes refer full results uploaded on website of stock exchanges and company. Single segment 2022-04-01 2023-03-31 Audited Standalone 208121400000.00 2790300000.00 210911700000.00 51656300000.00 11264600000.00 -2379300000.00 21569500000.00 4721800000.00 16008700000.00 61281700000.00 164123300000.00 46788400000.00 -29377900000.00 17410500000.00 503300000.00 0.00 503300000.00 0.00 16907200000.00 0.00 0.00 0.00 0.00 16907200000.00 -110100000.00 16797100000.00 0.00 0.00 2399300000.00 1 235084300000.00 7.00 7.00 0.00 0.00 7.00 7.00 Net (gain) / loss on foreign currency transactions 51800000.00 Other expenses 17337600000.00 Net (gain) / loss on foreign currency transactions -502600000.00 Other expenses 61784300000.00 47332500000.00 3288700000.00 1208000000.00 38576200000.00 5240400000.00 124161400000.00 6327000000.00 538900000.00 131027300000.00 10323900000.00 8226400000.00 245223400000.00 39891900000.00 2002600000.00 71250200000.00 4102800000.00 110000000.00 33470300000.00 5824000000.00 116759900000.00 7785700000.00 164437500000.00 214000000.00 409874900000.00 2399300000.00 235084300000.00 237483600000.00 237483600000.00 75867300000.00 5727300000.00 81594600000.00 2061600000.00 5074500000.00 88730700000.00 59400000.00 31255800000.00 40806500000.00 72121700000.00 3437700000.00 8095000000.00 83654400000.00 6200000.00 172391300000.00 409874900000.00 4721800000.00 -5854500000.00 -29320100000.00 0.00 -825300000.00 0.00 0.00 0.00 0.00 4063600000.00 0.00 -4985700000.00 0.00 16008700000.00 0.00 -19331800000.00 0.00 0.00 0.00 340000000.00 0.00 2202000000.00 0.00 0.00 0.00 -135200000.00 0.00 29500700000.00 0.00 -8019800000.00 9390700000.00 0.00 0.00 0.00 4319900000.00 0.00 5070800000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 83000000.00 9624300000.00 36952500000.00 36929500000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 159200000.00 60000000.00 0.00 0.00 0.00 1522300000.00 0.00 1043500000.00 0.00 -7051700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 82140500000.00 54900900000.00 0.00 348100000.00 25188800000.00 9600000.00 0.00 0.00 1693100000.00 -287800000.00 195300000.00 -92500000.00 4195300000.00 4102800000.00 Items that will not be reclassified to profit or loss -197900000.00 Items that will not be reclassified to profit or loss 23200000.00 -197900000.00 23200000.00 -69200000.00 8100000.00 Items that may be reclassified to profit or loss 827200000.00 Items that may be reclassified to profit or loss -192400000.00 827200000.00 -192400000.00 289100000.00 -67200000.00